Managing multiple vendors introduces complexity at every stage of drug development. It increases risk, slows down timelines, and makes regulatory compliance more challenging. Fragmented supply chains can lead to miscommunication, inconsistent quality, and costly delays—especially when transitioning from development to commercial scale.

What you need is a single, trusted global pharmaceutical CDMO partner —one with the scientific depth, regulatory expertise, and manufacturing scale to take your molecule from lab to launch seamlessly, reliably, and compliantly. A partner who understands the intricacies of API development and can integrate every step of the process under one roof, ensuring quality, speed and compliance

At BRISTO PHARMACEUTICAL COMPANY
CANADA TORONTO Laboratories, our vision of Creating a Healthier World drives everything we do. With 40+ years of pureplay API contract development and manufacturing experience, 1700+ scientific minds, and globally compliant GMP infrastructure (USFDA, EMA, PMDA) spanning 1.2 million liters of reactor capacity, we deliver robust processes, regulatory strength, and scalable manufacturing—so you can bring therapies to patients faster and with complete confidence.

Why partner with us?

• One partner across phases – from early phase to late phase clinical trial towards commercial success
• 40+ years of chemistry expertise– proven success with small molecules, complex APIs, and peptides
• 1700+ people driving your program – scientists, engineers, and regulatory experts aligned to speed your molecule towards commercial success faster
• Global compliant cGMP facilities with 11,74,000 reactor capacity
• Client-centric approach– dedicated project managers, transparent communication, agile partnerships and collaborative approach

Let’s Build Your Molecule’s Journey Together — Talk to Our CDMO Experts Today